2026 ICD-10-CM Diagnosis Code C38.0Malignant neoplasm of heart

ICD-10-CM Codes›C00–D49›C30-C39›C38

ICD-10-CM C38.0
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C38.0 is a billable ICD-10-CM diagnosis code for malignant neoplasm of heart. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 314 through 316. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 2 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Cardiac cancers.

For Medicare Advantage risk adjustment, C38.0 maps to CMS-HCC Category 20 (Lung and Other Severe Cancers) under the V28 model, adding a risk factor of about 1.136 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
C38.0
Billable Status
Yes — Valid for Submission
Code Describes
Malignant neoplasm of heart
Short Description
Malignant neoplasm of heart
Same as the full description in the CMS dataset.
Parent Code
Malignant neoplasm of heart, mediastinum and pleura

Code Classification

ChapterC00–D49Neoplasms
SectionC30-C39Malignant neoplasms of respiratory and intrathoracic organs
CategoryC38Malignant neoplasm of heart, mediastinum and pleura
This CodeC38.0Malignant neoplasm of heart

Medicare Risk Adjustment (HCC)Billing

C38.0 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 20— Lung and Other Severe Cancers
Payment HCC · PY 2026 one of 233 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+1.136
community, non-dual, aged · ranges 0.672–1.214 across segments
Hierarchy
Superseded by HCC 17, HCC 18, and HCC 19
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 11
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 11 · ESRD (V21): HCC 11 · ESRD (V24): HCC 11
ESRD V21 weights: 0.076 dialysis, 0.284–0.298 functioning graft · ESRD V24 weights: 0.059 dialysis, 0.257–0.362 functioning graft
Part D (RxHCC)
RxHCC 20 — Lung, Kidney, and Other Cancers; Secondary Cancer of Lymph Nodes and Other Sites
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Malignant germ cell neoplasm of heart
  • Malignant germ cell neoplasm of mediastinum
  • Malignant neoplasm of endocardium
  • Malignant neoplasm of heart
  • Malignant neoplasm of myocardium
  • Malignant neoplasm of pericardium
  • Neoplasm of endocardium
  • Neoplasm of epicardium
  • Neoplasm of myocardium
  • Primary angiosarcoma of heart
  • Primary angiosarcoma of thorax
  • Primary angiosarcoma of trunk
  • Primary malignant neoplasm of endocardium
  • Primary malignant neoplasm of epicardium
  • Primary malignant neoplasm of heart
  • Primary malignant neoplasm of myocardium
  • Primary malignant neoplasm of pericardium

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Malignant neoplasm of pericardium

Type 1 Excludes

  • malignant neoplasm of great vessels C49.3

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO011
Cardiac cancers
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Endocardium

    the innermost layer of the heart, comprised of endothelial cells.
  • Myocardial Stunning

    prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity.
  • Myocardium

    the muscle tissue of the heart. it is composed of striated, involuntary muscle cells (myocytes, cardiac) connected to form the contractile pump to generate blood flow.
  • Pericardial Fluid

    watery fluid produced in the serous and visceral pericardium surrounding the surface of the heart.
  • Pericardium

    a conical fibro-serous sac surrounding the heart and the roots of the great vessels (aorta; venae cavae; pulmonary artery). pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. the latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
atrium, cardiacC38.0C79.89–D15.1D48.7D49.89
endocardiumC38.0C79.89–D15.1D48.7D49.89
epicardiumC38.0C79.89–D15.1D48.7D49.89
heartC38.0C79.89–D15.1D48.7D49.89
myocardiumC38.0C79.89–D15.1D48.7D49.89
myopericardiumC38.0C79.89–D15.1D48.7D49.89
pericardiumC38.0C79.89–D15.1D48.7D49.89
ventricle (cerebral) (floor) (lateral) (third) › cardiac (left) (right)C38.0C79.89–D15.1D48.7D49.89

Patient EducationClinical

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.

The full article covers:

  • What is cancer?
  • What are the types of cancer?
  • How does cancer develop?
  • What are the symptoms of cancer?
  • How is cancer diagnosed?
  • What are the treatments for cancer?
  • Can cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C38.0 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
164.1 Malignant neopl heart
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C38.0Overview

What is the ICD-10 code for malignant neoplasm of heart?

The ICD-10-CM code for malignant neoplasm of heart is C38.0 (sometimes written as C380). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is C38.0 (Malignant neoplasm of heart, mediastinum and pleura) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of heart on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C38.0 group to?

When malignant neoplasm of heart is the principal diagnosis on an inpatient stay, it groups to MS-DRG 314, 315, 316, with relative weights from 0.6821 to 2.0852 depending on complications. Higher weights mean higher Medicare reimbursement.

Is C38.0 a CC or MCC?

CMS lists C38.0 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 2 closely related codes in its exclusion list.

What is the ICD-9 equivalent of C38.0?

Under the General Equivalence Mappings, malignant neoplasm of heart converts to ICD-9-CM 164.1 (malignant neopl heart). The mapping is approximate, so confirm the match fits the documentation.

What HCC is C38.0?

C38.0 (malignant neoplasm of heart) maps to CMS-HCC Category 20 (Lung and Other Severe Cancers), commonly written as HCC 20, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 11 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 20.

Does C38.0 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, C38.0 adds a risk adjustment factor of about 1.136 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.672 to 1.214 depending on the payment segment). A more severe related category (HCC 17, HCC 18, and HCC 19) supersedes it when both are reported. See the full factor table on the HCC 20 category page.